BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35925681)

  • 1. Relieving DYRK1A repression of MKL1 confers an adult-like phenotype to human infantile megakaryocytes.
    Elagib KE; Brock A; Clementelli CM; Mosoyan G; Delehanty LL; Sahu RK; Pacheco-Benichou A; Fruit C; Besson T; Morris SW; Eto K; Jobaliya C; French DL; Gadue P; Singh S; Shi X; Qin F; Cornelison R; Li H; Iancu-Rubin C; Goldfarb AN
    J Clin Invest; 2022 Oct; 132(19):. PubMed ID: 35925681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pivotal role of PDK1 in megakaryocyte cytoskeletal dynamics and polarization during platelet biogenesis.
    Geue S; Aurbach K; Manke MC; Manukjan G; Münzer P; Stegner D; Brähler C; Walker-Allgaier B; Märklin M; Borst CE; Quintanilla-Fend L; Rath D; Geisler T; Salih HR; Seizer P; Lang F; Nieswandt B; Gawaz M; Schulze H; Pleines I; Borst O
    Blood; 2019 Nov; 134(21):1847-1858. PubMed ID: 31578203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OP9 bone marrow stroma cells differentiate into megakaryocytes and platelets.
    Matsubara Y; Ono Y; Suzuki H; Arai F; Suda T; Murata M; Ikeda Y
    PLoS One; 2013; 8(3):e58123. PubMed ID: 23469264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-125a-5p regulates megakaryocyte proplatelet formation via the actin-bundling protein L-plastin.
    Bhatlekar S; Manne BK; Basak I; Edelstein LC; Tugolukova E; Stoller ML; Cody MJ; Morley SC; Nagalla S; Weyrich AS; Rowley JW; O'Connell RM; Rondina MT; Campbell RA; Bray PF
    Blood; 2020 Oct; 136(15):1760-1772. PubMed ID: 32844999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional characterization of human megakaryocyte polyploidization and lineage commitment.
    Choudry FA; Bagger FO; Macaulay IC; Farrow S; Burden F; Kempster C; McKinney H; Olsen LR; Huang N; Downes K; Voet T; Uppal R; Martin JF; Mathur A; Ouwehand WH; Laurenti E; Teichmann SA; Frontini M
    J Thromb Haemost; 2021 May; 19(5):1236-1249. PubMed ID: 33587817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes.
    Liu ZJ; Italiano J; Ferrer-Marin F; Gutti R; Bailey M; Poterjoy B; Rimsza L; Sola-Visner M
    Blood; 2011 Apr; 117(15):4106-17. PubMed ID: 21304100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of Grin1 in mouse megakaryocytes reveals NMDA receptor role in platelet function and proplatelet formation.
    Hearn JI; Green TN; Hisey CL; Bender M; Josefsson EC; Knowlton N; Baumann J; Poulsen RC; Bohlander SK; Kalev-Zylinska ML
    Blood; 2022 Apr; 139(17):2673-2690. PubMed ID: 35245376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Megakaryocyte ontogeny: Clinical and molecular significance.
    Elagib KE; Brock AT; Goldfarb AN
    Exp Hematol; 2018 May; 61():1-9. PubMed ID: 29501467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genomic and proteomic blueprint of mouse megakaryocytes derived from embryonic stem cells.
    Merico V; Zuccotti M; Carpi D; Baev D; Mulas F; Sacchi L; Bellazzi R; Pastorelli R; Redi CA; Moratti R; Garagna S; Balduini A
    J Thromb Haemost; 2012 May; 10(5):907-15. PubMed ID: 22372922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mimicking megakaryopoiesis in vitro using biomaterials: Recent advances and future opportunities.
    Ingavle G; Shabrani N; Vaidya A; Kale V
    Acta Biomater; 2019 Sep; 96():99-110. PubMed ID: 31319203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Don't you forget about me(gakaryocytes).
    Tilburg J; Becker IC; Italiano JE
    Blood; 2022 Jun; 139(22):3245-3254. PubMed ID: 34582554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role for MKL1 in megakaryocytic maturation.
    Cheng EC; Luo Q; Bruscia EM; Renda MJ; Troy JA; Massaro SA; Tuck D; Schulz V; Mane SM; Berliner N; Sun Y; Morris SW; Qiu C; Krause DS
    Blood; 2009 Mar; 113(12):2826-34. PubMed ID: 19136660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Miniaturized 3D bone marrow tissue model to assess response to Thrombopoietin-receptor agonists in patients.
    Di Buduo CA; Laurent PA; Zaninetti C; Lordier L; Soprano PM; Ntai A; Barozzi S; La Spada A; Biunno I; Raslova H; Bussel JB; Kaplan DL; Balduini CL; Pecci A; Balduini A
    Elife; 2021 Jun; 10():. PubMed ID: 34059198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation.
    Haddad E; Cramer E; Rivière C; Rameau P; Louache F; Guichard J; Nelson DL; Fischer A; Vainchenker W; Debili N
    Blood; 1999 Jul; 94(2):509-18. PubMed ID: 10397718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linkage between the mechanisms of thrombocytopenia and thrombopoiesis.
    Eto K; Kunishima S
    Blood; 2016 Mar; 127(10):1234-41. PubMed ID: 26787737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release.
    Mattia G; Vulcano F; Milazzo L; Barca A; Macioce G; Giampaolo A; Hassan HJ
    Blood; 2002 Feb; 99(3):888-97. PubMed ID: 11806991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered cord blood megakaryocytes evade killing by allogeneic T-cells for refractory thrombocytopenia.
    Kumar B; Afshar-Kharghan V; Mendt M; Sackstein R; Tanner MR; Popat U; Ramdial J; Daher M; Jimenez J; Basar R; Melo Garcia L; Shanley M; Kaplan M; Wan X; Nandivada V; Reyes Silva F; Woods V; Gilbert A; Gonzalez-Delgado R; Acharya S; Lin P; Rafei H; Banerjee PP; Shpall EJ
    Front Immunol; 2022; 13():1018047. PubMed ID: 36203567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Tropomyosin Receptor Kinase A Signaling Negatively Regulates Megakaryopoiesis and induces Thrombopoiesis.
    Kizilyer A; Singh MV; Singh VB; Suwunnakorn S; Palis J; Maggirwar SB
    Sci Rep; 2019 Feb; 9(1):2781. PubMed ID: 30808933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The heterogeneity of megakaryocytes and platelets and implications for ex vivo platelet generation.
    Liu C; Huang B; Wang H; Zhou J
    Stem Cells Transl Med; 2021 Dec; 10(12):1614-1620. PubMed ID: 34536061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel chemical-structure TPOR agonist, TMEA, promotes megakaryocytes differentiation and thrombopoiesis via mTOR and ERK signalings.
    Jiang X; Sun Y; Yang S; Wu Y; Wang L; Zou W; Jiang N; Chen J; Han Y; Huang C; Wu A; Zhang C; Wu J
    Phytomedicine; 2023 Feb; 110():154637. PubMed ID: 36610353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.